Low Risk MDS - AAMDSIF Spring Virtual Conference | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Low Risk MDS - AAMDSIF Spring Virtual Conference

Myelodysplastic Syndromes (MDS)
Presentation Date: 
Fri, 04/24/2020 - 8:00pm (EDT)

Rami Komrokji, MD, Moffitt Cancer Center, Florida, provides a comprehensive overview of lower risk MDS from diagnosis to treatment. Dr. Komrokji focuses on how hematologists and oncologists use different tools to assess the risk for patients when diagnosed with MDS including an overview of IPSS-R. He also explains how this assessment tool is only useful prior to treatment and that after interventions, other assessment tools are used by healthcare professionals to provide guidance and support to patients, families and caregivers. Dr. Komrokhi further discusses the treatment landscape including the newly announced luspatercept and several prospective treatments in the pipeline/clinical trial phase.